Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombect…
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Which Medtech Giant Would Buy Inspire Medical Systems? The market may be focused on temporary hurdles, but a strategic acquirer would see a unique technology at a strong price. | ||
 TFX vs. PEN: Which Stock Is the Better Value Option? TFX vs. PEN: Which Stock Is the Better Value Option? | ||
 Is ANGO a Buy as Med Tech Growth Battles Persistent Margin Pressure? AngioDynamics' Med Tech growth and reimbursement gains strengthen its outlook, but tariffs, rising costs and execution risks keep the buy case uncertain. | ||
 Penumbra (PEN) Following THUNDERBOLT Debut, Is The Stock A Bargain Or Fairly Valued Penumbra (PEN) is back in focus after Novant Health reported successful use of its newly cleared THUNDERBOLT computer assisted vacuum thrombectomy system at a North Carolina comprehensive stroke center. See our latest analysis for Penumbra. At a share price of $318.73, Penumbra has seen a 1 year total shareholder return of 36.74%, while the 3 year and 5 year total shareholder returns of 3.46% and 19.72% suggest more moderate longer term progress as investors weigh new products like... | ||
Penumbra (PEN) Wins FDA Clearance For THUNDERBOLT After Strong Stroke Study Penumbra (NYSE:PEN) received FDA clearance for its THUNDERBOLT computer-assisted vacuum thrombectomy system for acute ischemic stroke treatment. The THUNDER study reported strong safety and efficacy results for THUNDERBOLT in stroke care. A leading stroke center has begun using THUNDERBOLT in clinical practice, expanding its real world footprint. Penumbra, traded on the NYSE under ticker PEN, focuses on medical devices for neuro and vascular conditions, including stroke. The FDA clearance... | ||
 3 Medical Device Stocks Giving Investors a Different Healthcare Play Globus Medical, Inspire Medical Systems, and Penumbra show varied revenue growth and analyst ratings, offering medical device investors alternatives to traditional pharmaceutical stocks. | ||
 IQV vs. PEN: Which Stock Is the Better Value Option? IQV vs. PEN: Which Stock Is the Better Value Option? | ||
MMT Newswires | ||
IInsider Monkey | ||